Ironwood Pharmaceuticals Files 8-K on Operations

Ticker: IRWD · Form: 8-K · Filed: May 7, 2025 · CIK: 1446847

Ironwood Pharmaceuticals Inc 8-K Filing Summary
FieldDetail
CompanyIronwood Pharmaceuticals Inc (IRWD)
Form Type8-K
Filed DateMay 7, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: operations, financials, filing

TL;DR

Ironwood Pharma filed an 8-K on May 7th about their financials. No numbers yet, but it's an official update.

AI Summary

Ironwood Pharmaceuticals, Inc. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition, and filing financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.

Why It Matters

This filing indicates Ironwood Pharmaceuticals is providing updates on its financial performance and condition, which is crucial for investors to assess the company's health.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for reporting operational and financial information, with no immediate indication of significant negative events.

Key Players & Entities

  • Ironwood Pharmaceuticals, Inc. (company) — Registrant
  • May 7, 2025 (date) — Date of Earliest Event Reported
  • 100 Summer Street, Suite 2300 (location) — Principal Executive Offices Address
  • Boston, Massachusetts (location) — Principal Executive Offices City and State
  • 02110 (location) — Principal Executive Offices Zip Code

FAQ

What specific financial information is being reported in this 8-K?

The provided text indicates the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail specific figures.

When was the earliest event reported in this filing?

The earliest event reported was on May 7, 2025.

What is the principal executive office address for Ironwood Pharmaceuticals, Inc.?

The principal executive office is located at 100 Summer Street, Suite 2300, Boston, Massachusetts 02110.

What is the Commission File Number for Ironwood Pharmaceuticals, Inc.?

The Commission File Number is 001-34620.

What is the Standard Industrial Classification code for Ironwood Pharmaceuticals, Inc.?

The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.